CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today announced that Humana, a large healthcare third-party payor, upgraded the CardioNet System to a “covered benefit” status. Previously, the CardioNet System was categorized by Humana as “experimental-investigational.”
